High-Performance Liquid Chromatography (HPLC) is the standard analytical technique used to quantify the chemical purity of retatrutide. It separates the target 39-amino-acid peptide from synthesis truncations, diastereomers, and impurities, calculating purity as a percentage of total integrated chromatographic peak area.
In solid-phase peptide synthesis (SPPS), retatrutide ($C_{221}H_{342}N_{46}O_{68}$) is assembled amino acid by amino acid from the C-terminus to the N-terminus. Even with 99.5% step-wise coupling efficiency, synthesizing a 39-amino-acid sequence with a C18 fatty diacid side-chain yields minor deletion sequences, incomplete deprotections, and oxidation artifacts.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is employed to purify and analyze the crude product. It utilizes a non-polar stationary phase (typically silica particles bonded with octadecyl carbon chains, $C_{18}$) and an aqueous/organic mobile phase gradient under high pressure (often exceeding 2,000 to 5,000 psi).
Separation is governed by the relative hydrophobicity of molecules. The peptide sample is loaded in an aqueous buffer (Mobile Phase A: $H_2O$ with 0.1% trifluoroacetic acid [TFA]). The hydrophobic peptide binds to the $C_{18}$ matrix. As the concentration of organic modifier (Mobile Phase B: Acetonitrile with 0.1% TFA) gradually ramps up, the retatrutide peptide desorbs and elutes at a distinct Retention Time ($R_t$).
As the separated compounds flow through the HPLC flow cell, a UV spectrophotometer records optical absorbance at 214 nm (the characteristic absorbance band of peptide backbone peptide bonds). The resulting signal area under each peak corresponds to the amount of light absorbed.
For example, if the primary retatrutide peak integrates to 4,971,000 $\mu V \cdot s$ and the sum of all trace contaminant peaks is 29,000 $\mu V \cdot s$, the calculated purity is: $(4971000 / 5000000) \times 100 = \mathbf{99.42\%}$.
A critical point of analytical rigor is distinguishing between a specification threshold and a measured assay result:
The pre-determined quality standard that a synthesized batch must meet to be released (e.g., ≥ 99.00% HPLC purity). It represents the lower boundary limit.
The empirical quantitative value measured on that specific lot by the testing instrument (e.g., 99.42% for Batch TIC633), as documented on the signed Certificate of Analysis.
Peptides Hub clearly prints both the specification requirement and the exact measured laboratory outcome on every published report.
Analytical Limitation: HPLC verifies chromatographic homogeneity, but it cannot definitively confirm chemical identity or molecular weight. Two different peptides with identical hydrophobic retention could elute at the exact same retention time.
For comprehensive verification, HPLC purity data must always be paired with Mass Spectrometry (MS), which ionizes the peptide to confirm its monoisotopic molecular mass of 4731.33 Da.